Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Transplant: looking to ASH 2019

Sergio Giralt • 26 Oct 2019
COSTEM 2019
General

Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) and what we can look forward to at ASH 2019. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Sergio Giralt

1:12
An update in cellular therapies: gene editing for SCD and immunotherapies for MM
Sergio Giralt • 8 Dec 2023
0:59
The role of radioimmunoconjugates in AML treatment: insights from the SIERRA trial
Sergio Giralt • 8 Dec 2023
2:03
The evolving role of transplantation in multiple myeloma in the age of novel immunotherapeutics
Sergio Giralt • 8 Dec 2023
1:29
Final results of KarMMa-3: ide-cel in R/R MM
Sergio Giralt • 8 Dec 2023

Related Videos

2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
The content of VJHemOnc is intended for healthcare professionals